Latest Breaking News On - Ilona nemeth - Page 1 : comparemela.com

 E-Mail The Seaver Autism Center for Research and Treatment at the Icahn School of Medicine at Mount Sinai and Rumi Scientific announced today that they will team up to initiate a drug discovery pipeline for rare genetic disorders that carry a high risk of autism. The project will initially involve the development and use of a platform that mimics the development of brain tissues, at high speed, allowing researchers to gain insights into how cells respond to three known genes implicated in autism. Over the past several years, more than 100 genes have been identified that confer very high risk to autism when mutated, and the Seaver Center at Mount Sinai is one of the lead sites for these autism gene discoveries, said Joseph D. Buxbaum, PhD, Director of the Seaver Autism Center for Research and Treatment at Mount Sinai and Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai. We are eager to work together with Rum

New yorkUnited statesLong islandIlona nemethJosephd buxbaumHealth systemSeaver center at mount sinaiMount sinai seaver centerSeaver autism centerIcahn school of medicine at mount sinaiGenomic sciencesMount sinai health systemIcahn school of medicineIcahn schoolMount sinaiRumi scientific